Amoy Diagnostics Co., Ltd.
Shenzhen Stock ExchangeTotal Valuation
Amoy Diagnostics Co., Ltd. carries a market capitalization of 7.04B, placing it among publicly traded companies globally. Its enterprise value stands at 7.32B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.
| Market Cap | 7.04B |
| Enterprise Value | 7.32B |
Share Statistics
Amoy Diagnostics Co., Ltd. currently has 391.54M shares outstanding.
| Shares Outstanding | 391.54M |
| Owned by Insiders (%) | N/A |
| Owned by Institutions (%) | N/A |
Valuation Ratios
Amoy Diagnostics Co., Ltd. trades at a trailing price-to-earnings ratio of 28.23. The price-to-sales ratio is 7.39, and the price-to-book ratio stands at 5.15.
| PE Ratio | 28.23 |
| PS Ratio | 7.39 |
| PB Ratio | 5.15 |
| P/TBV Ratio | 4.60 |
| P/FCF Ratio | 161.21 |
| P/OCF Ratio | N/A |
Enterprise Valuation
On an enterprise value basis, Amoy Diagnostics Co., Ltd. trades at an EV/EBITDA multiple of 21.02 and an EV/FCF ratio of 135.12. The EV/Sales ratio of 6.39 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 21.02 provides insight into valuation relative to core operating earnings.
| EV / Sales | 6.39 |
| EV / EBITDA | 21.02 |
| EV / EBIT | 21.02 |
| EV / FCF | 135.12 |
Financial Position
Amoy Diagnostics Co., Ltd. maintains a current ratio of 8.53, meaning it holds 8.5x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 4.08, indicating elevated leverage, while an interest coverage ratio of 182.18 demonstrates strong ability to service its debt obligations.
| Current Ratio | 8.53 |
| Quick Ratio | 5.45 |
| Debt / Equity | 4.08 |
| Debt / EBITDA | 0.22 |
| Interest Coverage | 182.18 |
Financial Efficiency
Amoy Diagnostics Co., Ltd. posts a return on equity of 19.14 and a return on invested capital of 15.72.
| Return on Equity (ROE) | 19.14 |
| Return on Assets (ROA) | 14.35 |
| Return on Invested Capital (ROIC) | 15.72 |
| Return on Capital Employed (ROCE) | 18.46 |
| Revenue Per Employee | N/A |
| Employee Count | N/A |
| Inventory Turnover | 4.84 |
Taxes
Over the trailing twelve months, Amoy Diagnostics Co., Ltd. has paid 50.92M in income taxes, reflecting an effective tax rate of 14.51.
| Income Tax | 50.92M |
| Effective Tax Rate | 14.51 |
Stock Price Statistics
Amoy Diagnostics Co., Ltd.'s stock has declined approximately -16.62818% over the past 52 weeks. The 50-day moving average sits at 18.97, while the 200-day moving average is 21.20.
| Beta (5Y) | N/A |
| 52-Week Price Change | -16.62818% |
| 50-Day Moving Average | 18.97 |
| 200-Day Moving Average | 21.20 |
| Average Volume (20 Days) | N/A |
Income Statement
Over the trailing twelve months, Amoy Diagnostics Co., Ltd. generated 1.15B in revenue and converted that into 300.04M in net income, yielding earnings per share of 0.76. EBITDA reached 348.16M, while operating income came in at 348.16M.
| Revenue | 1.15B |
| Gross Profit | 964.07M |
| Operating Income | 348.16M |
| Pretax Income | 350.97M |
| Net Income | 300.04M |
| EBITDA | 348.16M |
| EBIT | 348.16M |
| Earnings Per Share (EPS) | 0.76 |
Balance Sheet
Amoy Diagnostics Co., Ltd. holds 1.23B in cash and equivalents against 76.91M in total debt, resulting in a net debt position of -920.33M. Total book value stands at 1.64B, with working capital of 1.69B providing operational flexibility.
| Cash & Cash Equivalents | 1.23B |
| Total Debt | 76.91M |
| Net Debt | -920.33M |
| Equity (Book Value) | 1.64B |
| Book Value Per Share | 4.18 |
| Working Capital | 1.69B |
Cash Flow
After subtracting -52.53M in capital expenditures, free cash flow totaled -52.53M - equivalent to -0.13 per share.
| Operating Cash Flow | N/A |
| Capital Expenditures | -52.53M |
| Free Cash Flow | -52.53M |
| FCF Per Share | -0.13 |
Margins
Amoy Diagnostics Co., Ltd. operates with a gross margin of 84.18, reflecting its pricing power and cost economics. The operating margin of 30.40 and net profit margin of 26.20 provide insight into operational efficiency.
| Gross Margin | 84.18 |
| Operating Margin | 30.40 |
| Pretax Margin | 30.64 |
| Profit Margin | 26.20 |
| EBITDA Margin | 30.40 |
Dividends & Yields
The company's payout ratio of 34.97 indicates the proportion of earnings distributed to shareholders.
| Dividend Per Share | 0.27 |
| Dividend Yield | N/A |
| Payout Ratio | 34.97 |
| Shareholder Yield | 2.07 |
| FCF Yield | 0.62 |
Stock Splits
Amoy Diagnostics Co., Ltd.'s most recent stock split took place on May 31, 2022 with a 5:9 split ratio.
| Last Split Date | 5/31/2022 |
| Split Ratio | 5:9 |
Scores
Amoy Diagnostics Co., Ltd. posts an Altman Z-Score of 19.32, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.
| Altman Z-Score | 19.32 |